HomepageBHC • TSE
add
Bausch Health Companies Inc
Vorige slotkoers
$ 6,55
Dag-range
$ 6,41 - $ 6,65
Jaar-range
$ 5,45 - $ 13,74
Beurswaarde
2,41 mld. CAD
Gem. volume
451,19K
Koers/winst
-
Dividendrendement
-
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 2,26 mld. | 4,92% |
Bedrijfskosten | 1,29 mld. | 6,18% |
Netto inkomsten | -58,00 mln. | 9,38% |
Netto winstmarge | -2,57 | 13,47% |
Winst per aandeel | 0,61 | 2,86% |
EBITDA | 574,00 mln. | -7,27% |
Effectief belastingtarief | -82,98% | — |
Balans
Totale activa
Totale passiva
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 1,13 mld. | 54,71% |
Totale activa | 26,42 mld. | -1,83% |
Totale passiva | 26,66 mld. | -1,57% |
Totaal aandelenvermogen | -240,00 mln. | — |
Uitstaande aandelen | 369,55 mln. | — |
Koers-boekwaardeverhouding | -2,05 | — |
Rendement op activa | 2,54% | — |
Rendement op kapitaal | 3,14% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -58,00 mln. | 9,38% |
Operationele kasstroom | 211,00 mln. | 0,00% |
Kasstroom uit beleggingen | -130,00 mln. | -78,08% |
Kasstroom uit financiering | -146,00 mln. | 57,06% |
Nettomutatie in liquide middelen | -44,00 mln. | 78,74% |
Vrije kasstroom | 149,88 mln. | -51,81% |
Over
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in eye health, gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufacture and market branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.
On 13 July 2018, as Quebec, Canada-based Valeant Pharmaceuticals International, it changed its name to Bausch Health Companies. Wikipedia
CEO
Opgericht
1959
Hoofdvestiging
Website
Werknemers
20.700